Clinical Trials Directory

Trials / Completed

CompletedNCT05341687

Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.

Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in Patients With COVID-19 Associated Acute Respiratory Distress Syndrome (CARDS)

Status
Completed
Phase
Study type
Observational
Enrollment
122 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mortality of patients with COVID-19 associated acute respiratory distress syndrome (CARDS) treated with veno-venous extra-corporal membrane oxygenation (vv-ECMO) is increasing over time since the beginning of the COVID-19 pandemic. The objectives were to retrospectively describe over the first ten days after vv-ECMO implantation, the ventilatory management of CARDS and to assess the impact of static respiratory system compliance (CRS) on the first day of vv-ECMO on 180-day mortality.

Conditions

Interventions

TypeNameDescription
OTHERNo applicableNo applicable

Timeline

Start date
2020-01-03
Primary completion
2021-12-31
Completion
2023-05-01
First posted
2022-04-22
Last updated
2024-07-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05341687. Inclusion in this directory is not an endorsement.